ArticleScientific reports2020

Is the risk of second primary malignancy increased in multiple myeloma in the novel therapy era? A population-based, retrospective cohort study in Taiwan.

Yanfang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.